<DOC>
	<DOCNO>NCT00148564</DOCNO>
	<brief_summary>The purpose study evaluate effect different atypical antipsychotic weight change , energy homeostasis , metabolism , energy intake well activity . Patients schizophrenia schizoaffective disorder randomly assign treat ziprasidone olanzapine 24 week . Primary outcome parameter weight change 24 week .</brief_summary>
	<brief_title>Energy Homeostasis Under Treatment With Atypical Antipsychotics</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnosis schizophrenia relate disorder ( DSMIV ) Indication longterm treatment antipsychotic BMI 20 30 Weight change le 3kg last 3 month inclusion Informed consent Psychiatric comorbidity Depot antipsychotic last 2 month Antipsychotics last 2 week Treatment olanzapine , clozapine ziprasidone teh last 3 month Treatment drug , may lead weight change Significant endocrine , neurological , cardiovascular , hepatic , renal , metabolic , medical disease clinically relevant abnormality laboratory test Female subject pregnancy breastfeed Female subject within childbearing year use adequate birth control Patients judge investigator serious suicide risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>weight gain</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>atypical antipsychotic</keyword>
</DOC>